{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T16:19:21Z","timestamp":1790785161316,"version":"4.1.0"},"reference-count":68,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2020,1,17]],"date-time":"2020-01-17T00:00:00Z","timestamp":1579219200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,1,17]],"date-time":"2020-01-17T00:00:00Z","timestamp":1579219200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Marie and Emmett Carmichael fund for graduate students in biosciences (UAB)."}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neuropsychopharmacol."],"published-print":{"date-parts":[[2020,5]]},"DOI":"10.1038\/s41386-020-0614-2","type":"journal-article","created":{"date-parts":[[2020,1,17]],"date-time":"2020-01-17T08:02:56Z","timestamp":1579248176000},"page":"1059-1067","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":70,"title":["Downregulated AKT-mTOR signaling pathway proteins in dorsolateral prefrontal cortex in Schizophrenia"],"prefix":"10.1038","volume":"45","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2447-6313","authenticated-orcid":false,"given":"Radhika","family":"Chadha","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James H.","family":"Meador-Woodruff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,1,17]]},"reference":[{"key":"614_CR1","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/S0140-6736(15)01121-6","volume":"388","author":"MJ Owen","year":"2016","unstructured":"Owen MJ, Sawa A, Mortensen PB. Schizophrenia. Lancet. 2016;388:86\u201397.","journal-title":"Lancet."},{"key":"614_CR2","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1159\/000110430","volume":"20","author":"UE Lang","year":"2007","unstructured":"Lang UE, Puls I, M\u00fcller DJ, Strutz-Seebohm N, Gallinat J. Molecular mechanisms of schizophrenia. Cell Physiol Biochem. 2007;20:687\u2013702.","journal-title":"Cell Physiol Biochem"},{"key":"614_CR3","doi-asserted-by":"crossref","unstructured":"Meador-Woodruff JH. Novel D2-like dopamine receptors in schizophrenic brain. In: Search for the causes of schizophrenia. Heidelberg: Steinkopff; 1999. p. 251\u201360.","DOI":"10.1007\/978-3-642-47076-9_18"},{"key":"614_CR4","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/S0893-133X(96)00276-X","volume":"16","author":"J Joyce","year":"1997","unstructured":"Joyce J, Meador-Woodruff JH. Linking the family of D2 receptors to neuronal circuits in human brain: insights into schizophrenia. Neuropsychopharmacology. 1997;16:375\u201384.","journal-title":"Neuropsychopharmacology."},{"key":"614_CR5","unstructured":"Gao W. Dopaminergic and glutamatergic dysfunctions in the neuropathophysiology of schizophrenia. In Kudo E, Fujii Y (eds), Dopamine: functions, regulation and health effects. New York: Nova Science Publishers; 2011. p. 167\u2013194."},{"key":"614_CR6","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.2174\/138920112800784899","volume":"13","author":"RE McCullumsmith","year":"2012","unstructured":"McCullumsmith RE, Hammond J, Funk A, Meador-Woodruff JH. Recent advances in targeting the ionotropic glutamate receptors in treating schizophrenia. Curr Pharm Biotechnol. 2012;13:1535\u201342.","journal-title":"Curr Pharm Biotechnol"},{"key":"614_CR7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4062\/biomolther.2012.20.1.001","volume":"20","author":"MD Rubio","year":"2012","unstructured":"Rubio MD, Drummond JB, Meador-Woodruff JH. Glutamate receptor abnormalities in schizophrenia: implications for innovative treatments. Biomol Ther. 2012;20:1\u201318.","journal-title":"Biomol Ther"},{"key":"614_CR8","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1038\/s41537-017-0032-6","volume":"3","author":"JL McGuire","year":"2017","unstructured":"McGuire JL, Depasquale EA, Funk AJ, O\u2019Donnovan SM, Hasselfeld K, Marwaha S, et al. Abnormalities of signal transduction networks in chronic schizophrenia. NPJ Schizophr. 2017;3:30.","journal-title":"NPJ Schizophr"},{"key":"614_CR9","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1038\/npp.2011.267","volume":"37","author":"AJ Funk","year":"2012","unstructured":"Funk AJ, McCullumsmith RE, Haroutunian V, Meador-Woodruff JH. Abnormal activity of the MAPK- and cAMP-associated signaling pathways in frontal cortical areas in postmortem brain in schizophrenia. Neuropsychopharmacology. 2012;37:896\u2013905.","journal-title":"Neuropsychopharmacology."},{"key":"614_CR10","doi-asserted-by":"crossref","first-page":"33","DOI":"10.3389\/fnmol.2012.00033","volume":"5","author":"ES Emamian","year":"2012","unstructured":"Emamian ES. AKT\/GSK3 signaling pathway and schizophrenia. Front Mol Neurosci. 2012;5:33.","journal-title":"Front Mol Neurosci"},{"key":"614_CR11","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.brainres.2012.06.032","volume":"1470","author":"W Zheng","year":"2012","unstructured":"Zheng W, Wang H, Zeng Z, Lin J, Little PJ, Srivastava LK, et al. The possible role of the Akt signaling pathway in schizophrenia. Brain Res. 2012;1470:145\u201358.","journal-title":"Brain Res."},{"key":"614_CR12","first-page":"752563","volume":"2012","author":"Y Kitagishi","year":"2012","unstructured":"Kitagishi Y, Kobayashi M, Kikuta K, Matsuda S. Roles of PI3K\/AKT\/GSK3\/mTOR pathway in cell signaling of mental illnesses. Depress Res Treat. 2012;2012:752563.","journal-title":"Depress Res Treat"},{"key":"614_CR13","doi-asserted-by":"publisher","unstructured":"Levenga J, Wong H, Milstead RA, Keller BN, LaPlante LE, Hoeffer CA. AKT isoforms have distinct hippocampal expression and roles in synaptic plasticity. Elife. 2017;6. https:\/\/doi.org\/10.7554\/eLife.30640.","DOI":"10.7554\/eLife.30640"},{"key":"614_CR14","doi-asserted-by":"crossref","first-page":"18471","DOI":"10.1073\/pnas.1109680108","volume":"108","author":"K Radwanska","year":"2011","unstructured":"Radwanska K, Medvedev NI, Pereira GS, Engmann O, Thiede N, Moraes MFD, et al. Mechanism for long-term memory formation when synaptic strengthening is impaired. Proc Natl Acad Sci USA. 2011;108:18471\u20135.","journal-title":"Proc Natl Acad Sci USA"},{"key":"614_CR15","first-page":"19","volume":"2","author":"Y Liao","year":"2010","unstructured":"Liao Y, Hung M-C. Physiological regulation of Akt activity and stability. Am J Transl Res. 2010;2:19\u201342.","journal-title":"Am J Transl Res"},{"key":"614_CR16","doi-asserted-by":"crossref","first-page":"e0175993","DOI":"10.1371\/journal.pone.0175993","volume":"12","author":"KR Howell","year":"2017","unstructured":"Howell KR, Floyd K, Law AJ. PKB\u03b3\/AKT3 loss-of-function causes learning and memory deficits and deregulation of AKT\/mTORC2 signaling: Relevance for schizophrenia. PLoS ONE. 2017;12:e0175993.","journal-title":"PLoS One."},{"key":"614_CR17","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1007\/s00726-008-0230-7","volume":"38","author":"M Rosner","year":"2010","unstructured":"Rosner M, Siegel AN, Valli AA, Fuchs AC, Hengstschl\u00e4ger AM. mTOR phosphorylated at S2448 binds to raptor and rictor. Amino Acids. 2010;38:223\u20138.","journal-title":"Amino Acids."},{"key":"614_CR18","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1038\/nrneurol.2016.81","volume":"12","author":"PB Crino","year":"2016","unstructured":"Crino PB. The mTOR signalling cascade: paving new roads to cure neurological disease. Nat Rev Neurol. 2016;12:379\u201392.","journal-title":"Nat Rev Neurol"},{"key":"614_CR19","doi-asserted-by":"crossref","unstructured":"Wang X, Proud CG. The mTOR pathway in the control of protein synthesis. Am Physiol Soc. 2006. http:\/\/physiologyonline.physiology.org\/content\/nips\/21\/5\/362.full.pdf. Accessed 21 Apr 2017.","DOI":"10.1152\/physiol.00024.2006"},{"key":"614_CR20","doi-asserted-by":"publisher","unstructured":"Jhanwar-Uniyal M, Amin AG, Cooper JB, Das K, Schmidt MH, Murali R. Discrete signaling mechanisms of mTORC1 and mTORC2: connected yet apart in cellular and molecular aspects. Adv Biol Regul. 2017. https:\/\/doi.org\/10.1016\/j.jbior.2016.12.001.","DOI":"10.1016\/j.jbior.2016.12.001"},{"key":"614_CR21","doi-asserted-by":"crossref","first-page":"E1453","DOI":"10.1152\/ajpendo.00660.2011","volume":"302","author":"C Wiza","year":"2012","unstructured":"Wiza C, Nascimento EBM, Ouwens DM. Role of PRAS40 in Akt and mTOR signaling in health and disease. Am J Physiol Endocrinol Metab. 2012;302:E1453\u201360.","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"614_CR22","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.tins.2009.11.003","volume":"33","author":"CA Hoeffer","year":"2010","unstructured":"Hoeffer CA, Klann E. mTOR signaling: at the crossroads of plasticity, memory and disease. Trends Neurosci. 2010;33:67\u201375.","journal-title":"Trends Neurosci."},{"key":"614_CR23","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1016\/j.cub.2004.06.054","volume":"14","author":"DS Dos","year":"2004","unstructured":"Dos DS, Ali SM, Kim D-H, Guertin DA, Latek RR, Erdjument-Bromage H, et al. Rictor, a novel binding partner of mTOR, defines a rapamycin-insensitive and raptor-independent pathway that regulates the cytoskeleton. Curr Biol. 2004;14:1296\u2013302.","journal-title":"Curr Biol."},{"key":"614_CR24","first-page":"326","volume":"18","author":"DA Fortin","year":"2012","unstructured":"Fortin DA, Srivastava T, Soderling TR. Structural modulation of dendritic spines during synaptic plasticity. Neuroscience. 2012;18:326\u201341.","journal-title":"Neuroscience"},{"key":"614_CR25","doi-asserted-by":"publisher","unstructured":"English J, Fan Y, F\u00f6cking M, Lopez L, Hryniewiecka M, Wynne K, et al. Reduced protein synthesis in schizophrenia patient-derived olfactory cells. Transl Psychiatry. 2015;5. https:\/\/doi.org\/10.1038\/tp.2015.119.","DOI":"10.1038\/tp.2015.119"},{"key":"614_CR26","doi-asserted-by":"crossref","unstructured":"Laguesse S, Ron D. Protein translation and psychiatric disorders. Neurosci. 2019;25.","DOI":"10.1177\/1073858419853236"},{"key":"614_CR27","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.neuroscience.2012.04.044","volume":"251","author":"JR Glausier","year":"2013","unstructured":"Glausier JR, Lewis DA. Dendritic spine pathology in schizophrenia. Neuroscience. 2013;251:90\u2013107.","journal-title":"Neuroscience."},{"key":"614_CR28","doi-asserted-by":"crossref","DOI":"10.1038\/s41398-017-0045-y","volume":"7","author":"HP Bhambhvani","year":"2017","unstructured":"Bhambhvani HP, Mueller TM, Simmons MS, Meador-Woodruff JH. Actin polymerization is reduced in the anterior cingulate cortex of elderly patients with schizophrenia. Transl Psychiatry. 2017;7:1278.","journal-title":"Transl Psychiatry."},{"key":"614_CR29","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1038\/ng1296","volume":"36","author":"ES Emamian","year":"2004","unstructured":"Emamian ES, Hall D, Birnbaum MJ, Karayiorgou M, Gogos JA. Convergent evidence for impaired AKT1-GSK3\u03b2 signaling in schizophrenia. Nat Genet. 2004;36:131\u20137.","journal-title":"Nat Genet."},{"key":"614_CR30","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.schres.2006.02.009","volume":"84","author":"Z Zhao","year":"2006","unstructured":"Zhao Z, Ksiezak-Reding H, Riggio S, Haroutunian V, Pasinetti GM. Insulin receptor deficits in schizophrenia and in cellular and animal models of insulin receptor dysfunction. Schizophr Res. 2006;84:1\u201314.","journal-title":"Schizophr Res."},{"key":"614_CR31","doi-asserted-by":"publisher","unstructured":"Stoica L, Zhu PJ, Huang W, Zhou H, Kozma SC, Costa-Mattioli M. Selective pharmacogenetic inhibition of mammalian target of Rapamycin complex I (mTORC1) blocks long-term synaptic plasticity and memory storage. PNAS. 2011. https:\/\/doi.org\/10.1073\/pnas.1014715108.","DOI":"10.1073\/pnas.1014715108"},{"key":"614_CR32","volume":"9","author":"P Kim","year":"2019","unstructured":"Kim P, Scott MR, Meador-Woodruff JH. Abnormal ER quality control of neural GPI-anchored proteins via dysfunction in ER export processing in the frontal cortex of elderly subjects with schizophrenia. Transl Psychiatry. 2019;9:6.","journal-title":"Transl Psychiatry."},{"key":"614_CR33","doi-asserted-by":"publisher","unstructured":"Scott MR, Meador-Woodruff JH. Intracellular compartment-specific proteasome dysfunction in postmortem cortex in schizophrenia subjects. Mol Psychiatry. 2019;1\u201315. https:\/\/doi.org\/10.1038\/s41380-019-0359-7.","DOI":"10.1038\/s41380-019-0359-7"},{"key":"614_CR34","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.schres.2015.06.002","volume":"166","author":"JM Kippe","year":"2015","unstructured":"Kippe JM, Mueller TM, Haroutunian V, Meador-Woodruff JH. Abnormal N-acetylglucosaminyltransferase expression in prefrontal cortex in schizophrenia. Schizophr Res. 2015;166:219\u201324.","journal-title":"Schizophr Res."},{"key":"614_CR35","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.schres.2004.11.001","volume":"75","author":"MK Harte","year":"2005","unstructured":"Harte MK, Bachus SB, Reynolds GP. Increased N-acetylaspartate in rat striatum following long-term administration of haloperidol. Schizophr Res. 2005;75:303\u20138.","journal-title":"Schizophr Res"},{"key":"614_CR36","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1016\/0006-3223(86)90126-5","volume":"21","author":"K Kashihara","year":"1986","unstructured":"Kashihara K, Sato M, Fujiwara Y, Harada T, Ogawa T, Otsuki S. Effects of intermittent and continuous haloperidol administration on the dopaminergic system in the rat brain. Biol Psychiatry. 1986;21:650\u20136.","journal-title":"Biol Psychiatry."},{"key":"614_CR37","doi-asserted-by":"crossref","first-page":"2110","DOI":"10.1038\/npp.2010.87","volume":"35","author":"JC Hammond","year":"2010","unstructured":"Hammond JC, McCullumsmith RE, Funk AJ, Haroutunian V, Meador-Woodruff JH. Evidence for abnormal forward trafficking of AMPA receptors in frontal cortex of elderly patients with schizophrenia. Neuropsychopharmacology. 2010;35:2110\u20139.","journal-title":"Neuropsychopharmacology."},{"key":"614_CR38","doi-asserted-by":"crossref","first-page":"e39190","DOI":"10.1371\/journal.pone.0039190","volume":"7","author":"JC Hammond","year":"2012","unstructured":"Hammond JC, Meador-Woodruff JH, Haroutunian V, McCullumsmith RE. Ampa receptor subunit expression in the endoplasmic reticulum in frontal cortex of elderly patients with schizophrenia. PLoS ONE. 2012;7:e39190.","journal-title":"PLoS One."},{"key":"614_CR39","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1097\/WNR.0b013e328363bd8a","volume":"24","author":"J Tucholski","year":"2013","unstructured":"Tucholski J, Simmons MS, Pinner AL, McMillan LD, Haroutunian V, Meador-Woodruff JH. N-linked glycosylation of cortical N-methyl-D-aspartate and kainate receptor subunits in schizophrenia. Neuroreport. 2013;24:688\u201391.","journal-title":"Neuroreport."},{"key":"614_CR40","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.schres.2016.01.054","volume":"177","author":"AL Pinner","year":"2016","unstructured":"Pinner AL, Tucholski J, Haroutunian V, McCullumsmith RE, Meador-Woodruff JH. Decreased protein S-palmitoylation in dorsolateral prefrontal cortex in schizophrenia. Schizophr Res. 2016;177:78\u201387.","journal-title":"Schizophr Res."},{"key":"614_CR41","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1007\/s00702-008-0143-3","volume":"116","author":"DE Bauer","year":"2009","unstructured":"Bauer DE, Haroutunian V, McCullumsmith RE, Meador-Woodruff JH. Expression of four housekeeping proteins in elderly patients with schizophrenia. J Neural Transm. 2009;116:487\u201391.","journal-title":"J Neural Transm"},{"key":"614_CR42","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/j.schres.2018.02.010","volume":"197","author":"P Kim","year":"2018","unstructured":"Kim P, Scott MR, Meador-Woodruff JH. Abnormal expression of ER quality control and ER associated degradation proteins in the dorsolateral prefrontal cortex in schizophrenia. Schizophr Res. 2018;197:484\u201391.","journal-title":"Schizophr Res."},{"key":"614_CR43","doi-asserted-by":"publisher","unstructured":"Xu Y, Yao Shugart Y, Wang G, Cheng Z, Jin C, Zhang K, et al. Altered expression of mRNA profiles in blood of early-onset schizophrenia. Sci Rep. 2016;6. https:\/\/doi.org\/10.1038\/srep16767.","DOI":"10.1038\/srep16767"},{"key":"614_CR44","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1038\/nature13716","volume":"515","author":"Z Wen","year":"2014","unstructured":"Wen Z, Nam Nguyen H, Guo Z, Lalli MA, Wang X, Su Y, et al. Synaptic dysregulation in a human iPS cell model of mental disorders HHS Public Access. Nature. 2014;515:414\u20138.","journal-title":"Nature."},{"key":"614_CR45","doi-asserted-by":"publisher","unstructured":"Hoffman GE, Hartley BJ, Flaherty E, Ladran I, Gochman P, Ruderfer DM, et al. Transcriptional signatures of schizophrenia in hiPSC-derived NPCs and neurons are concordant with post-mortem adult brains. Nat Commun. 2017;8. https:\/\/doi.org\/10.1038\/s41467-017-02330-5.","DOI":"10.1038\/s41467-017-02330-5"},{"key":"614_CR46","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1016\/j.biopsych.2017.03.018","volume":"82","author":"D Arion","year":"2017","unstructured":"Arion D, Huo Z, Enwright JF, Corradi JP, Tseng G, Lewis DA. Transcriptome alterations in prefrontal pyramidal cells distinguish schizophrenia from bipolar and major depressive disorders. Biol Psychiatry. 2017;82:594\u2013600.","journal-title":"Biol Psychiatry."},{"key":"614_CR47","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1038\/mp.2014.171","volume":"20","author":"D Arion","year":"2015","unstructured":"Arion D, Corradi JP, Tang S, Datta D, Boothe F, He A, et al. Distinctive transcriptome alterations of prefrontal pyramidal neurons in schizophrenia and schizoaffective disorder. Mol Psychiatry. 2015;20:1397\u2013405.","journal-title":"Mol Psychiatry"},{"key":"614_CR48","doi-asserted-by":"crossref","first-page":"baw100","DOI":"10.1093\/database\/baw100","volume":"2016","author":"AD Rouillard","year":"2016","unstructured":"Rouillard AD, Gundersen GW, Fernandez NF, Wang Z, Monteiro CD, McDermott MG, et al. The harmonizome: a collection of processed datasets gathered to serve and mine knowledge about genes and proteins. Database. 2016;2016:baw100.","journal-title":"Database."},{"key":"614_CR49","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.brainres.2014.04.029","volume":"1568","author":"JL McGuire","year":"2014","unstructured":"McGuire JL, Hammond JH, Yates SD, Chen D, Haroutunian V, Meador-Woodruff JH, et al. Altered serine\/threonine kinase activity in schizophrenia. Brain Res. 2014;1568:42\u201354.","journal-title":"Brain Res."},{"key":"614_CR50","doi-asserted-by":"publisher","unstructured":"Costa-Mattioli M, Monteggia LM. mTOR complexes in neurodevelopmental and neuropsychiatric disorders. Nat Publ Gr. 2013;16. https:\/\/doi.org\/10.1038\/nn.3546.","DOI":"10.1038\/nn.3546"},{"key":"614_CR51","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1016\/j.biopsych.2004.07.023","volume":"56","author":"M Ikeda","year":"2004","unstructured":"Ikeda M, Iwata N, Suzuki T, Kitajima T, Yamanouchi Y, Kinoshita Y, et al. Association of AKT1 with schizophrenia confirmed in a Japanese population. Biol Psychiatry. 2004;56:698\u2013700.","journal-title":"Biol Psychiatry."},{"key":"614_CR52","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1002\/ajmg.b.30291","volume":"141B","author":"SN Bajestan","year":"2006","unstructured":"Bajestan SN, Sabouri AH, Nakamura M, Takashima H, Keikhaee MR, Behdani F, et al. Association of AKT1 haplotype with the risk of schizophrenia in Iranian population. Am J Med Genet Part B Neuropsychiatr Genet. 2006;141B:383\u20136.","journal-title":"Am J Med Genet Part B Neuropsychiatr Genet"},{"key":"614_CR53","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1002\/hipo.20887","volume":"22","author":"DT Balu","year":"2012","unstructured":"Balu DT, Carlson GC, Talbot K, Kazi H, Hill-Smith TE, Easton RM, et al. Akt1 deficiency in schizophrenia and impairment of hippocampal plasticity and function. Hippocampus. 2012;22:230\u201340.","journal-title":"Hippocampus."},{"key":"614_CR54","doi-asserted-by":"crossref","first-page":"18802","DOI":"10.1074\/jbc.M512524200","volume":"281","author":"R Gong","year":"2006","unstructured":"Gong R, Park CS, Abbassi NR, Tang S-J. Roles of glutamate receptors and the mammalian target of rapamycin (mTOR) signaling pathway in activity-dependent dendritic protein synthesis in hippocampal neurons. J Biol Chem. 2006;281:18802\u201315.","journal-title":"J Biol Chem"},{"key":"614_CR55","doi-asserted-by":"crossref","first-page":"20748","DOI":"10.1074\/jbc.M115.638023","volume":"290","author":"W-L Hsu","year":"2015","unstructured":"Hsu W-L, Chung H-W, Wu C-Y, Wu H-I, Lee Y-T, Chen E-C, et al. Glutamate stimulates local protein synthesis in the axons of rat cortical neurons by activating \u03b1-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptors and metabotropic glutamate receptors. J Biol Chem. 2015;290:20748\u201360.","journal-title":"J Biol Chem"},{"key":"614_CR56","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1038\/nn.3351","volume":"16","author":"W Huang","year":"2013","unstructured":"Huang W, Zhu PJ, Zhang S, Zhou H, Stoica L, Galiano M, et al. mTORC2 controls actin polymerization required for consolidation of long-term memory. Nat Neurosci. 2013;16:441\u20138.","journal-title":"Nat Neurosci."},{"key":"614_CR57","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1007\/s12031-016-0872-y","volume":"61","author":"L Wang","year":"2017","unstructured":"Wang L, Zhou K, Fu Z, Yu D, Huang H, Zang X, et al. Brain development and Akt signaling: the crossroads of signaling pathway and neurodevelopmental diseases. J Mol Neurosci. 2017;61:379\u201384.","journal-title":"J Mol Neurosci"},{"key":"614_CR58","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1038\/sj.mp.4001844","volume":"11","author":"LV Kristiansen","year":"2006","unstructured":"Kristiansen LV, Beneyto M, Haroutunian V, Meador-Woodruff JH. Changes in NMDA receptor subunits and interacting PSD proteins in dorsolateral prefrontal and anterior cingulate cortex indicate abnormal regional expression in schizophrenia. Mol Psychiatry. 2006;11:737\u201347.","journal-title":"Mol Psychiatry."},{"key":"614_CR59","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.celrep.2017.06.038","volume":"20","author":"KT Thomas","year":"2017","unstructured":"Thomas KT, Anderson BR, Shah N, Zimmer SE, Hawkins D, Valdez AN, et al. Inhibition of the schizophrenia-associated microRNA miR-137 disrupts Nrg1\u03b1 neurodevelopmental signal transduction. Cell Rep. 2017;20:1\u201312.","journal-title":"Cell Rep."},{"key":"614_CR60","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1097\/WNR.0b013e32832d30d9","volume":"20","author":"AJ Funk","year":"2009","unstructured":"Funk AJ, Rumbaugh G, Harotunian V, McCullumsmith RE, Meador-Woodruff JH. Decreased expression of NMDA receptor-associated proteins in frontal cortex of elderly patients with schizophrenia. Neuroreport. 2009;20:1019\u201322.","journal-title":"Neuroreport."},{"key":"614_CR61","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1111\/jnc.12622","volume":"129","author":"A Gururajan","year":"2014","unstructured":"Gururajan A, Van Den Buuse M. Is the mTOR-signalling cascade disrupted in Schizophrenia? J Neurochem. 2014;129:377\u201387.","journal-title":"J Neurochem"},{"key":"614_CR62","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1038\/emm.2007.39","volume":"39","author":"M-S Roh","year":"2007","unstructured":"Roh M-S, Seo MS, Kim Y, Kim SH, Jeon WJ, Ahn YM, et al. Haloperidol and clozapine differentially regulate signals upstream of glycogen synthase kinase 3 in the rat frontal cortex. Exp Mol Med. 2007;39:353\u201360.","journal-title":"Exp Mol Med"},{"key":"614_CR63","doi-asserted-by":"publisher","unstructured":"Pan B, Huang XF, Deng C. Aripiprazole and haloperidol activate GSK3\u03b2-dependent signalling pathway differentially in various brain regions of rats. Int J Mol Sci. 2016;17. https:\/\/doi.org\/10.3390\/ijms17040459.","DOI":"10.3390\/ijms17040459"},{"key":"614_CR64","doi-asserted-by":"crossref","unstructured":"Sarbassov DD, Bulgakova O, Bersimbaev RI, Shaiken T. Isolation of the mTOR complexes by affinity purification. In: Methods in molecular biology. Humana Press; 2012. p. 59\u201374.","DOI":"10.1007\/978-1-61779-430-8_5"},{"key":"614_CR65","doi-asserted-by":"crossref","first-page":"17833","DOI":"10.1073\/pnas.1419425111","volume":"111","author":"A Jain","year":"2014","unstructured":"Jain A, Arauz E, Aggarwal V, Ikon N, Chen J, Ha T. Stoichiometry and assembly of mTOR complexes revealed by single-molecule pulldown. Proc Natl Acad Sci USA. 2014;111:17833\u20138.","journal-title":"Proc Natl Acad Sci USA"},{"key":"614_CR66","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1016\/j.cub.2004.06.054","volume":"14","author":"DS Dos","year":"2004","unstructured":"Dos DS, Ali SM, Kim D-H, Guertin DA, Latek RR, Erdjument-Bromage H, et al. Rictor, a novel binding partner of mTOR, defines a rapamycin-insensitive and raptor-independent pathway that regulates the cytoskeleton. Curr Biol. 2004;14:1296\u2013302.","journal-title":"Curr Biol."},{"key":"614_CR67","first-page":"1512","volume":"5","author":"R De Sousa Abreu","year":"2009","unstructured":"De Sousa Abreu R, Penalva LO, Marcotte EM, Vogel C. Global signatures of protein and mRNA expression levels. Mol Biosyst. 2009;5:1512\u201326.","journal-title":"Mol Biosyst."},{"key":"614_CR68","doi-asserted-by":"publisher","unstructured":"Macdonald ML, Garver M, Newman J, Sun Z, Kannarkat J, Salisbury R, et al. Synaptic proteome alterations in the primary auditory cortex of individuals with schizophrenia. JAMA Psychiatry. 2019. https:\/\/doi.org\/10.1001\/jamapsychiatry.2019.2974.","DOI":"10.1001\/jamapsychiatry.2019.2974"}],"container-title":["Neuropsychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41386-020-0614-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41386-020-0614-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41386-020-0614-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T21:08:19Z","timestamp":1684616899000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41386-020-0614-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1,17]]},"references-count":68,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2020,5]]}},"alternative-id":["614"],"URL":"https:\/\/doi.org\/10.1038\/s41386-020-0614-2","relation":{},"ISSN":["0893-133X","1740-634X"],"issn-type":[{"value":"0893-133X","type":"print"},{"value":"1740-634X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,1,17]]},"assertion":[{"value":"11 October 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 January 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 January 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 January 2020","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}